when did semaglutide get approved FDA Approves Oral Semaglutide: First GLP-1 Weight Loss Pill The Indian government has approved
Description
Lab monitoring (e.g., liver function, B12 levels) may be recommended depending on your clinical situation
Contraindications may include a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or a history of pancreatitis

Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity
During this discussion, they may evaluate your individual health conditions, such as your risk for diabetic retinopathy, hypoglycemia, or pancreatitis, especially if you are currently using sulfonylureas or other blood-sugarlowering medications

Another obesity medicine maker, Eli Lilly, which makes Zepbound, also raised its sales outlook this week

Patients should be monitored for signs of theophylline toxicity, and theophylline plasma levels should be checked if necessary
